Enteric Microorganisms in Rheumatoid Diseases: Causative Agents and Possible Mechanisms

1985 ◽  
Vol 48 (6) ◽  
pp. 538-545 ◽  
Author(s):  
DOUGLAS L. ARCHER
Keyword(s):  
Immune Response ◽  
Ankylosing Spondylitis ◽  
Molecular Mechanisms ◽  
Enteric Pathogens ◽  
Gastrointestinal Illness ◽  
Hla B27 ◽  
Causative Agents ◽  
Related Individuals ◽  
Rheumatoid Diseases

The role of foodborne enteric pathogens in the development of three seronegative spondarthropathies (ankylosing spondylitis, Reiter's disease and reactive arthritis) is discussed. Although the prevalence of the HLA-B27 antigen in blood-related individuals suggests a genetic predisposition to these diseases, exogenous environmental factors are also indicated. A clinical profile is given to clarify certain relationships of the seronegative arthropathies. Evidence of the involvement of enteric pathogens in the onset of these conditions following gastrointestinal illness is considered along with the interactions of general and molecular mechanisms of the disease processes and the immune response.

HLA-B27 in the Greek Cypriot population: Distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27—related diseases. The possible protective role of B*2707

2004 ◽  
Vol 65 (12) ◽  
pp. 1451-1454 ◽  
Author(s):  
Agathi Varnavidou-Nicolaidou ◽  
Katerina Karpasitou ◽  
Dora Georgiou ◽  
Galatia Stylianou ◽  
Avgousta Kokkofitou ◽  
...  
Keyword(s):  
Ankylosing Spondylitis ◽  
Population Distribution ◽  
Protective Role ◽  
Hla B27 ◽  
Greek Cypriot

scholarly journals Role of HLA-B27 in the pathogenesis of ankylosing spondylitis

2017 ◽  
Vol 15 (4) ◽  
pp. 1943-1951 ◽  
Author(s):  
Bin Chen ◽  
Jia Li ◽  
Chongru He ◽  
Dahe Li ◽  
Wenwen Tong ◽  
...  
Keyword(s):  
Ankylosing Spondylitis ◽  
Hla B27

Etiopathogenic role of HLA-B27 alleles in ankylosing spondylitis

2005 ◽  
Vol 8 (3) ◽  
pp. 146-153 ◽  
Author(s):  
Nurullah AKKOC ◽  
Muhammad Asim KHAN
Keyword(s):  
Ankylosing Spondylitis ◽  
Hla B27

scholarly journals Lipophilicity of Bacteriochlorin-Based Photosensitizers as a Determinant for PDT Optimization through the Modulation of the Inflammatory Mediators

2019 ◽  
Vol 9 (1) ◽  
pp. 8 ◽  
Author(s):  
Barbara Pucelik ◽  
Luis G. Arnaut ◽  
Janusz M. Dąbrowski
Keyword(s):  
Immune Response ◽  
Molecular Mechanisms ◽  
Near Infrared ◽  
Antitumor Immune Response ◽  
Infrared Light ◽  
Gm Csf ◽  
Hydrophobic Compound ◽  
Tnf Α ◽  
Wide Range

Photodynamic therapy (PDT) augments the host antitumor immune response, but the role of the PDT effect on the tumor microenvironment in dependence on the type of photosensitizer and/or therapeutic protocols has not been clearly elucidated. We employed three bacteriochlorins (F2BOH, F2BMet and Cl2BHep) of different polarity that absorb near-infrared light (NIR) and generated a large amount of reactive oxygen species (ROS) to compare the PDT efficacy after various drug-to-light intervals: 15 min. (V-PDT), 3h (E-PDT) and 72h (C-PDT). We also performed the analysis of the molecular mechanisms of PDT crucial for the generation of the long-lasting antitumor immune response. PDT-induced damage affected the integrity of the host tissue and developed acute (protocol-dependent) local inflammation, which in turn led to the infiltration of neutrophils and macrophages. In order to further confirm this hypothesis, a number of proteins in the plasma of PDT-treated mice were identified. Among a wide range of cytokines (IL-6, IL-10, IL-13, IL-15, TNF-α, GM-CSF), chemokines (KC, MCP-1, MIP1α, MIP1β, MIP2) and growth factors (VEGF) released after PDT, an important role was assigned to IL-6. PDT protocols optimized for studied bacteriochlorins led to a significant increase in the survival rate of BALB/c mice bearing CT26 tumors, but each photosensitizer (PS) was more or less potent, depending on the applied DLI (15 min, 3 h or 72 h). Hydrophilic (F2BOH) and amphiphilic (F2BMet) PSs were equally effective in V-PDT (>80 cure rate). F2BMet was the most efficient in E-PDT (DLI = 3h), leading to a cure of 65 % of the animals. Finally, the most powerful PS in the C-PDT (DLI = 72 h) regimen turned out to be the most hydrophobic compound (Cl2BHep), allowing 100 % of treated animals to be cured at a light dose of only 45 J/cm2.

scholarly journals A review of the pathogenesis of ankylosing spondylitis

2008 ◽  
Vol 24 (1) ◽  
pp. E2 ◽  
Author(s):  
Elias Dakwar ◽  
Jaypal Reddy ◽  
Fernando L. Vale ◽  
Juan S. Uribe
Keyword(s):  
Ankylosing Spondylitis ◽  
Strong Association ◽  
Critical Role ◽  
Axial Skeleton ◽  
Causative Role ◽  
Hla B27 ◽  
Pathogenic Role ◽  
The Past ◽  
New Findings

✓ Ankylosing spondylitis (AS) is a chronic, progressive inflammatory rheumatic disease involving primarily the sacroiliac joints and the axial skeleton. The main clinical features are back pain and progressive stiffness of the spine. Oligoarthritis of the hips and shoulders, enthesopathy, and anterior uveitis are common, and involvement of the heart and lungs is rare. The current understanding of the pathogenesis of this disorder is limited. Despite the strong association between human leukocyte antigen B27 (HLA-B27) and susceptibility to AS reported over the past 30 years, the exact pathogenic role of HLA-B27 in AS and other spondyloarthropathies has yet to be determined. The authors present a review of the literature pertaining to the pathogenesis of AS over the past several decades. Ankylosing spondylitis is a polygenic disorder, with HLA-B27 playing a critical causative role in its pathogenesis. Animal studies of the immunobiology of HLA-B27 have provided significant insight into the pathogenic role of HLA-B27. The search for the antigenic peptide to support the “arthritogenic peptide” hypothesis has been disappointing. Over the past decade there has been increasing interest in the critical role of the misfolding and unfolded protein response of the heavy chain HLA-B27 in the modulation of the inflammatory response. Although there have been significant new findings in the understanding of the pathogenesis of AS, the exact mechanisms have yet to be identified. There is considerable optimism that additional susceptibility genes, predisposing factors, and regulators of the inflammatory process will be identified that will provide avenues for future treatment.

scholarly journals Role of the cellular immunity in the formation of the immune response in coronavirus infections

2021 ◽  
Vol 23 (6) ◽  
pp. 1229-1238
Author(s):  
I. A. Ivanova ◽  
N. D. Omelchenko ◽  
A. V. Filippenko ◽  
A. A. Trufanova ◽  
A. K. Noskov
Keyword(s):  
Immune Response ◽  
T Cells ◽  
Cellular Immunity ◽  
Memory T Cells ◽  
Adaptive Immune Response ◽  
Cell Immune Response ◽  
Adaptive Immune ◽  
Specific Memory ◽  
Causative Agents

The data obtained during previous epidemics caused by coronaviruses, and current pandemic indicate that assessing the role of certain immune interactions between these viruses and the microorganism is the main pre-requisite for development of diagnostic test systems as well as effective medical drugs and preventive measures. The review summarizes the results of studying patho– and immunogenesis of SARSCoV, MERS-CoV, and SARS-CoV-2 infections. These coronaviruses were proven to suppress development of adaptive immune response at the stage of its induction, affecting the number and functional activity of lymphocytes, effectors of cellular immunity, causing impairment of lymphopoiesis, apoptosis and «depletion» of these cells, thus leading to longer duration of the disease and increased viral load. Information about the role of cellular immunity in development of immune response to coronaviruses is presented. It was proven that the causative agents of SARS, MERS and COVID-19 trigger adaptive immune response in the microorganism according to both humoral and cellular types. Moreover, the synthesis of specific immunoglobulins does not yet point to presence of protective immune response. Activation of the cellular link of immunity is also important. A high degree of antigenic epitope homology in SARS-CoV, MERS-CoV and SARS-CoV-2 is described, thus suggesting an opportunity for cross-immunity to coronaviruses. The review addresses issues related to the terms of specific memory immune cells to SARS-CoV, MERS-CoV and SARS-CoV-2, and their role in providing long-term protection against these infections. Given that specific antibodies to SARS and MERS pathogens persisted for a year, were often not detected or briefly registered in patients with mild and asymptomatic infections, we can talk about important role of the cellular immune response in providing immunity to these coronaviruses. It was shown that, in contrast to antibodies, the antigen-specific memory T cells were registered in patients with SARS virus for 4 to 11 years, and Middle East Respiratory Syndrome – up to two years. Further research is needed to determine presence and number of memory T cells in COVID-19. A comparative analysis of data obtained during previous epidemics with respect to formation of adaptive immunity to coronaviruses. Description of proteins and epitopes recognized by human T lymphocytes will be useful in monitoring immune responses in COVID-19 patients, as well as in developing informative tests to study T cell immune response to SARS-CoV-2 and new preventive drugs.

Sign in / Sign up

Export Citation Format

Share Document